Middle East Veterinary Vaccine Industry Set to Reach USD 973.8 Million by 2033, Growing at a 4% CAGR

Global Veterinary Vaccines Market
Middle East Veterinary Vaccine Industry

The Middle East veterinary vaccine market, valued at US$ 627.1 million in 2023, is projected to expand steadily, achieving a valuation of US$ 973.8 million by 2033, with a CAGR of 4% over the forecast period.

Veterinary vaccines play a crucial role in safeguarding animal health and preventing the spread of infectious diseases, which, in turn, protects human health through improved food security and reduced zoonotic transmission.

A Full Report Analysis – https://www.futuremarketinsights.com/reports/middle-east-veterinary-vaccines-market

Key Market Drivers:

  • Rising Livestock Population: An increasing focus on livestock farming to meet the growing demand for meat, dairy, and other animal-derived products is driving vaccine demand.
  • Focus on Zoonotic Disease Prevention: With zoonotic diseases posing a global health challenge, vaccines are essential in curbing outbreaks and ensuring public health safety.
  • Government Initiatives: Strong government support for animal health programs and increased investment in veterinary infrastructure are bolstering the industry.
  • Companion Animal Care: Growing pet ownership and awareness about preventive healthcare for companion animals are contributing to market growth.

Market Outlook:

The Middle East veterinary vaccine market is poised for steady expansion as demand for effective immunization strategies continues to grow across livestock and companion animal sectors. Advancements in vaccine technology and increasing awareness of animal healthcare are expected to further drive adoption.

Growth Drivers

  1. Increasing Incidence of Animal Diseases: The rising prevalence of diseases in livestock and companion animals necessitates effective vaccination programs to ensure animal health and productivity.
  2. Rising Demand for Animal Protein: As the demand for meat and dairy products increases, there is a corresponding need for robust animal health management, including vaccinations, to prevent disease outbreaks.
  3. Awareness of Animal Health: Growing awareness regarding the importance of vaccination in maintaining animal health and preventing zoonotic diseases is driving market growth.
  4. Technological Advancements: Innovations in vaccine development, including the introduction of more effective and safer vaccine formulations, are enhancing the effectiveness of vaccination programs.

Regional Insights

  • The Middle East region has a significant focus on livestock vaccinations due to the high percentage of livestock in agricultural practices.
  • Countries such as Saudi Arabia and the UAE are expected to lead the market due to their investments in veterinary healthcare and infrastructure.

Competitive Landscape in the Middle East Veterinary Vaccine Industry

The Middle East veterinary vaccines industry’s competitive environment is defined by a broad array of players and entities, each of which contributes to the sector’s growth and development. Multinational pharmaceutical conglomerates like Zoetis, MSD Animal Health (Merck Animal Health in the United States and Canada), and Boehringer Ingelheim have a prominent presence in the region. These firms provide a wide range of vaccines, building on established brand awareness using their global reach and substantial research capabilities. Key players provide complete solutions to a wide range of animal health issues across the Middle East.

Recent Developments in the Middle East Veterinary Vaccine Industry

  • Bill Gates, Co-chair of the Bill & Melinda Gates Foundation, announced new investments at the 2023 Grand Challenges Annual Meeting in October 2023 to advance access to mRNA research and vaccine manufacturing technology. This will support low- and middle-income countries’ (LMICs’) capacity to develop large-scale, high-quality, lifesaving vaccines. The decision builds on the foundation’s more than 20 years of experience working with vaccine producers in LMICs, as well as the chance to use recent scientific discoveries to develop low-cost, high-quality health tools that reach more people throughout the world.
  • Kansas State University’s College of Veterinary Medicine announced the establishment of the new Center on Vaccine Evaluation and Alternatives for Antimicrobials, or CVEAA, in July 2023 to promote animal vaccine development and use.

Key Players in the Middle East Veterinary Vaccine Industry

  • JOVAC
  • Bioveta, Inc.
  • Intervac Pvt. Ltd.
  • Zoetis
  • Elanco
  • Merial
  • Merck & Co. Inc.
  • Bayer Pharma AG
  • Ceva
  • Boehringer Ingelheim
  • MSD Animal Health

Middle East Veterinary Vaccine Industry Segmentation

By Vaccine:

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
  • Others

By Animal:

  • Companion Animals
    • Canine
    • Avian
    • Feline
  • Livestock Animals
    • Aquatic
    • Bovine
    • Porcine
    • Small Ruminant
    • Poultry
  • Equine

By Disease Indication:

  • Foot and Mouth Disease
  • Newcastle Disease
  • PPRS
  • Canine Parvovirus
  • Brucellosis
  • Avian Influenza
  • Others

By End User:

  • Hospital Pharmacies
  • Veterinary Clinics
  • Private Veterinary Pharmacies
  • Others

By Country:

  • UAE
  • KSA
  • Turkey
  • Jordan
  • Sudan
  • Egypt
  • Rest of MEA

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *